Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
収録刊行物
-
- Drug Safety
-
Drug Safety 45 (8), 891-908, 2022-07-12
Springer Science and Business Media LLC